Dr. Musher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6620 Main St
Ste 1275
Houston, TX 77030Phone+1 713-798-3750Fax+1 713-798-2619- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2005 - 2008
University of WashingtonResidency, Internal Medicine, 2000 - 2003
Baylor College of MedicineClass of 2000
Certifications & Licensure
TX State Medical License 2009 - 2025
NC State Medical License 2017 - 2018
PA State Medical License 2004 - 2010
WA State Medical License 2003 - 2005- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- Study of Metformin With Simvastatin for Men With Prostate Carcinoma Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from ...Benjamin L Musher, Eric K Rowinsky, Brandon G Smaglo, Wasif Abidi, Mohamed Othman, Kalpesh Patel, Salmaan Jawaid, James Jing, Amanda Brisco, Ann M Leen, Mengfen Wu, Li...> ;The Lancet. Oncology. 2024 Apr 1
- 17 citationsPatient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).Ethan Basch, Amylou C Dueck, Sandra A Mitchell, Harvey Mamon, Martin Weiser, Leonard Saltz, Marc Gollub, Lauren Rogak, Brenda Ginos, Gina L Mazza, Brian Colgrove, Geor...> ;Journal of Clinical Oncology. 2023 Jul 20
- 1 citationsDevelopment of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer.Vivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, Ekin Tiu, Anirudh Joshi, Damir Vrabac, Hriday Bhambhvani, Katelyn Smith, Julia S Johansen, Shalini Makawita, Benjam...> ;Cell Reports. Medicine. 2023 Apr 18
- Join now to see all
Press Mentions
Rep. Joaquin Castro's Cancerous Tumors Are Rare but Manageable, Houston Experts SayFebruary 28th, 2023- Clinical Trials Offer Hope for Treatment of Pancreatic Cancer, the Third Leading Cause of Cancer-Related Deaths in the U.S.November 15th, 2022
- Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic CancerSeptember 8th, 2021
- Join now to see all
Hospital Affiliations
- Ben Taub General HospitalHouston, Texas
Houston Methodist HospitalHouston, Texas
St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Harris Health SystemHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
